These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9872685)

  • 21. Hemodynamic and perfusion end points for volemic resuscitation in sepsis. Shock 34(Suppl 1):34-39, 2010.
    Dahlqvist M; Hasibeder WR; Dünser MW
    Shock; 2011 Apr; 35(4):434; author reply 434-5. PubMed ID: 21407044
    [No Abstract]   [Full Text] [Related]  

  • 22. What's new in Shock? September 2014.
    Banerjee A
    Shock; 2014 Sep; 42(3):177-8. PubMed ID: 25122081
    [No Abstract]   [Full Text] [Related]  

  • 23. Year in review 2006: Critical Care--Multiple organ failure, sepsis, and shock.
    Simkova V; Baumgart K; Radermacher P; Barth E; Calzia E
    Crit Care; 2007; 11(4):221. PubMed ID: 17764584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Latest results of intensive care of sepsis, septic shock and multiple organ injuries].
    Incze F
    Orv Hetil; 1999 Mar; 140(10):515-20. PubMed ID: 10323066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis.
    Norrby-Teglund A; Haque KN; Hammarström L
    J Intern Med; 2006 Dec; 260(6):509-16. PubMed ID: 17116001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What's new in Shock? April 2015.
    Scott MJ
    Shock; 2015 Apr; 43(4):301-3. PubMed ID: 25768372
    [No Abstract]   [Full Text] [Related]  

  • 27. [Critical analysis of noninflammatory treatments of sepsis: lessons learned from previous trials].
    Montravers P; Lasocki S; Seguin P; Malledant Y
    Ann Fr Anesth Reanim; 2007 Apr; 26(4):363-9. PubMed ID: 17336486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-volume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs.
    Rimmelé T; Assadi A; Cattenoz M; Desebbe O; Lambert C; Boselli E; Goudable J; Etienne J; Chassard D; Bricca G; Allaouchiche B
    Nephrol Dial Transplant; 2009 Feb; 24(2):421-7. PubMed ID: 18799607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of immunomodulator derinat in the treatment of patients with surgical sepsis in traumatic shock].
    Gromov MI; Pivovarova LP
    Vestn Khir Im I I Grek; 2002; 161(6):45-8. PubMed ID: 12638492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Why is immune therapy in sepsis unsuccessful?].
    van Deventer SJ
    Ned Tijdschr Geneeskd; 1995 Mar; 139(11):548-9. PubMed ID: 7700389
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunomodulating strategies in the treatment of sepsis].
    Schultz MJ; van der Poll T
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2530-3. PubMed ID: 12532664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe sepsis trials: why have they failed?
    Dellinger RP
    Minerva Anestesiol; 1999 Jun; 65(6):340-5. PubMed ID: 10394797
    [No Abstract]   [Full Text] [Related]  

  • 33. Experimental models of gram-negative sepsis.
    Parker SJ; Watkins PE
    Br J Surg; 2001 Jan; 88(1):22-30. PubMed ID: 11136305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sepsis: state of the art.
    Marik PE; Varon J
    Dis Mon; 2001 Oct; 47(10):465-532. PubMed ID: 11641650
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunotherapy of sepsis: myth or reality?].
    Vinnitskiĭ LI; Vitvitskaia IM; Popov OIu
    Anesteziol Reanimatol; 1997; (3):89-97. PubMed ID: 9290000
    [No Abstract]   [Full Text] [Related]  

  • 36. The disconnect between animal models of sepsis and human sepsis.
    Rittirsch D; Hoesel LM; Ward PA
    J Leukoc Biol; 2007 Jan; 81(1):137-43. PubMed ID: 17020929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intensive care in surgical sepsis].
    Zviagin AA; Slepnev SIu
    Khirurgiia (Mosk); 1999; (10):16-20. PubMed ID: 10540547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety and efficacy of the use of vasopressin in sepsis and septic shock.
    Wilson SJ; Mehta SS; Bellamy MC
    Expert Opin Drug Saf; 2005 Nov; 4(6):1027-39. PubMed ID: 16255662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective functions of intracellular heat-shock protein (HSP) 70-expression in patients with severe sepsis.
    Bruemmer-Smith S; Stüber F; Schroeder S
    Intensive Care Med; 2001 Dec; 27(12):1835-41. PubMed ID: 11797016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Significance of the synergistic effect between endotoxin and gram-positive bacteria in the pathogenesis of sepsis].
    Yao YM; Sheng ZY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Apr; 17(4):193-6. PubMed ID: 15836817
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.